Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth £65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.
Current stock price: 13.84p, closed up 4.5% on Friday in London
12-month change: down 63%
By Tom Waite, Alliance News editor
Comments and questions to newsroom@alliancenews.com
Copyright 2022 Alliance News Ltd. All Rights Reserved.